Robert L. Bevins, Ph.D. - Publications
Affiliations: | 2005 | University of Kentucky, Lexington, KY |
Area:
ToxicologyYear | Citation | Score | |||
---|---|---|---|---|---|
2006 | Song L, Bevins R, Anderson BD. Kinetics and mechanisms of activation of alpha-amino acid ester prodrugs of camptothecins. Journal of Medicinal Chemistry. 49: 4344-55. PMID 16821794 DOI: 10.1021/Jm060016L | 0.346 | |||
2006 | Tangirala RS, Antony S, Agama K, Pommier Y, Anderson BD, Bevins R, Curran DP. Synthesis and biological assays of E-ring analogs of camptothecin and homocamptothecin. Bioorganic & Medicinal Chemistry. 14: 6202-12. PMID 16793274 DOI: 10.1016/J.Bmc.2006.05.073 | 0.392 | |||
2005 | Bevins RL, Zimmer SG. It's about time: scheduling alters effect of histone deacetylase inhibitors on camptothecin-treated cells. Cancer Research. 65: 6957-66. PMID 16061681 DOI: 10.1158/0008-5472.Can-05-0836 | 0.462 | |||
2002 | Du W, Curran DP, Bevins RL, Zimmer SG, Zhang J, Burke TG. Synthesis and evaluation of a novel E-ring modified alpha-hydroxy keto ether analogue of camptothecin. Bioorganic & Medicinal Chemistry. 10: 103-10. PMID 11738612 DOI: 10.1016/S0968-0896(01)00252-8 | 0.458 | |||
2001 | Bom D, Curran DP, Zhang J, Zimmer SG, Bevins R, Kruszewski S, Howe JN, Bingcang A, Latus LJ, Burke TG. The highly lipophilic DNA topoisomerase I inhibitor DB-67 displays elevated lactone levels in human blood and potent anticancer activity. Journal of Controlled Release : Official Journal of the Controlled Release Society. 74: 325-33. PMID 11489514 DOI: 10.1016/S0168-3659(01)00343-1 | 0.456 | |||
Show low-probability matches. |